Table 2. Categorical variables of subjects demographics.

NYHA: New York Heart Association; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; ACEI/ARB: angiotensin-converting enzyme inhibitors/angiotensin receptors blockers.

Gender	47.4% male (N=55)	52.6% female (N=61)
Previous functional status	79.3% Independent (N=92)	19.0% Partial dependency (N=22)	1.7% Total dependency (N=2)
NYHA class at admission	0.9% Class II (N= 1)	27.6% Class III (N= 32)	71.6% Class IV (N= 83)
NYHA class at discharge	16.5% Class I (N= 19)	68.7% Class II (N= 79)	13.9% Class III (N= 16)	0.9% Class IV (N= 1)	0.9% Missing (N=1)
Current smoker	88.8% non-smoker (N= 103)	11.2% Smoker (N=13)
DM	54.3% No DM (N=63)	45.7% with DM (N=53)
COPD	85.3% No COPD (N=99)	14.7% with COPD (N=17)
Dementia	91.4% No dementia (N=106)	8.6% with dementia (N=10)
Beta-blockers at discharge	30.2% No beta-blockers (N=35)	69.8% with beta-blockers (N=81)
ACEI/ARB medication at discharge	34.5% No ACEI/ARB (N=40)	65.5% with ACEI/ARB (N=76)
Use of psychopharmacs	63.8% No psychopharmacs (N=74)	36.2% with psychopharmacs (N=42)